Details

Autor(en) / Beteiligte

• Wu, Huan-Yi
• Chang, Peng-Hao
• Huang, Yu-Shan
• Tsai, Chin-Shiang
• Chen, Kuan-Yu
• Lin, I-Fan
• Hsih, Wen-Hsin
• Tsai, Wan-Lin
• Chen, Jiun-An
• Yang, Te-Liang
• Lee, Chun-Yuan
• Ho, Tzong-Shiann
• Wang, Hsiao-Wei
• Huang, Shiang-Fen
• Wu, Alice Ying-Jung
• Chen, Hung-Jui
• Chen, Yi-Ching
• Chen, Wan-Chen
• Tseng, Chien-Hao
• Lin, Pei-Chin
• Yang, Ching-Hsiang
• Hong, Pi-Lien
• Lee, Susan Shin-Jung
• Chen, Yao-Shen
• Liu, Yung-Ching
• Wang, Fu-Der
• Chan, Yu-Jiun
• Chang, Feng-Yee
• Chang, Hou-Tai
• Chen, Yee-Chun
• Chen, Yen-Hsu
• Cheng, Ming-Fang
• Chi, Hsin
• Chiu, Cheng-Hsun
• Ho, Mao-Wang
• Hsieh, Szu-Min
• Hsueh, Po-Ren
• Huang, Chien-Hsien
• Hung, Chien-Ching
• Hwang, Kao-Pin
• Kao, Kuo-Chin
• Ko, Wen-Chien
• Kuo, Chien-Feng
• Lai, Chung-Hsu
• Lee, Nan-Yao
• Lee, Shin-Jung
• Lin, Hsi-Hsun
• Lin, Yi-Tsung
• Liu, Ching-Chuan
• Liu, Po-Yu
• Lu, Po-Liang
• Lu, Chun-Yi
• Sheng, Wang-Huei
• Tang, Hung-Jen
• Tsai, Hung-Chin
• Wu, Ting-Shu
• Yang, Chia-Jui

Titel

Recommendations and guidelines for the diagnosis and management of Coronavirus Disease-19 (COVID-19) associated bacterial and fungal infections in Taiwan

Ist Teil von

• Journal of microbiology, immunology and infection, 2023-04, Vol.56 (2), p.207-235

Ort / Verlag

England: Elsevier B.V

Erscheinungsjahr

2023

Link zum Volltext

Quelle

Free E-Journal (出版社公開部分のみ）

Beschreibungen/Notizen

• Coronavirus disease-19 (COVID-19) is an emerging infectious disease caused by SARS-CoV-2 that has rapidly evolved into a pandemic to cause over 600 million infections and more than 6.6 million deaths up to Nov 25, 2022. COVID-19 carries a high mortality rate in severe cases. Co-infections and secondary infections with other micro-organisms, such as bacterial and fungus, further increases the mortality and complicates the diagnosis and management of COVID-19. The current guideline provides guidance to physicians for the management and treatment of patients with COVID-19 associated bacterial and fungal infections, including COVID-19 associated bacterial infections (CABI), pulmonary aspergillosis (CAPA), candidiasis (CAC) and mucormycosis (CAM). Recommendations were drafted by the 7th Guidelines Recommendations for Evidence-based Antimicrobial agents use Taiwan (GREAT) working group after review of the current evidence, using the grading of recommendations assessment, development, and evaluation (GRADE) methodology. A nationwide expert panel reviewed the recommendations in March 2022, and the guideline was endorsed by the Infectious Diseases Society of Taiwan (IDST). This guideline includes the epidemiology, diagnostic methods and treatment recommendations for COVID-19 associated infections. The aim of this guideline is to provide guidance to physicians who are involved in the medical care for patients with COVID-19 during the ongoing COVID-19 pandemic.